Financial reports
ARS
2023 FY
Annual report to shareholders
10 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
12 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
4 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Completion of Acquisition or Disposition of Assets
12 Mar 24
8-K
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
26 Feb 24
8-K
Completion of Acquisition or Disposition of Assets
6 Feb 24
8-K
Completion of Acquisition or Disposition of Assets
29 Jan 24
8-K
Completion of Acquisition or Disposition of Assets
2 Jan 24
8-K
Completion of Acquisition or Disposition of Assets
19 Dec 23
8-K
Entry into a Material Definitive Agreement
13 Nov 23
8-K
TransMedics Reports Third Quarter 2023 Financial Results
6 Nov 23
8-K
Completion of Acquisition or Disposition of Assets
22 Sep 23
8-K
Completion of Acquisition or Disposition of Assets
12 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
4 Aug 23
424B5
Prospectus supplement for primary offering
5 Aug 22
424B5
Prospectus supplement for primary offering
3 Aug 22
S-3ASR
Automatic shelf registration
3 Aug 22
S-8
Registration of securities for employees
1 Mar 22
424B5
Prospectus supplement for primary offering
27 May 20
424B5
Prospectus supplement for primary offering
26 May 20
S-3
Shelf registration
6 May 20
S-8
Registration of securities for employees
6 May 19
424B4
Prospectus supplement with pricing info
2 May 19
Proxies
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
DEFA14A
Additional proxy soliciting materials
22 Apr 22
DEFA14A
Additional proxy soliciting materials
20 Apr 22
DEF 14A
Definitive proxy
20 Apr 22
DEFA14A
Additional proxy soliciting materials
16 Apr 21
DEF 14A
Definitive proxy
16 Apr 21
DEFA14A
Additional proxy soliciting materials
14 Apr 20
Other
EFFECT
Notice of effectiveness
22 May 20
UPLOAD
Letter from SEC
19 May 20
CORRESP
Correspondence with SEC
19 May 20
CORRESP
Correspondence with SEC
19 May 20
CT ORDER
Confidential treatment order
14 May 19
EFFECT
Notice of effectiveness
2 May 19
CERT
Certification of approval for exchange listing
2 May 19
CORRESP
Correspondence with SEC
29 Apr 19
CORRESP
Correspondence with SEC
29 Apr 19
CORRESP
Correspondence with SEC
29 Apr 19
Ownership
4
Waleed H Hassanein
18 Apr 24
4
Waleed H Hassanein
12 Apr 24
4
Tamer I Khayal
10 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
4
Tamer I Khayal
5 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
4
Stephen Gordon
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
18 Mar 24